IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.01718-07v1
76/6/2603    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Shaw, C. A.
Right arrow Articles by Starnbach, M. N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaw, C. A.
Right arrow Articles by Starnbach, M. N.

 Previous Article  |  Next Article 

Infection and Immunity, June 2008, p. 2603-2611, Vol. 76, No. 6
0019-9567/08/$08.00+0     doi:10.1128/IAI.01718-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Both CD4+ and CD8+ T Cells Respond to Antigens Fused to Anthrax Lethal Toxin {triangledown}

Christine A. Shaw and Michael N. Starnbach*

Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115

Received 21 December 2007/ Returned for modification 21 February 2008/ Accepted 10 March 2008

The lethal toxin produced by Bacillus anthracis is a bipartite toxin in which the first protein, protective antigen (PA), transports the second protein, lethal factor, across the host cell membrane. We have previously shown that CD8+ T-cell epitopes fused to a nontoxic derivative of lethal factor (LFn) are delivered into the host cell cytosol in a PA-dependent manner. Delivery of these antigens targets them to the intracellular major histocompatibility complex (MHC) class I processing and presentation pathway and leads to the stimulation of antigen-specific CD8+ T cells in vivo. In this report, we describe the generation and characterization of LFn fusion proteins that include not only a CD8+ T-cell epitope but also a CD4+ T-cell epitope. We first show that these fusion proteins induce antigen-specific CD4+ T-cell responses following incubation with dendritic cells in vitro or injection into mice. Stimulation of CD4+ T cells by LFn fusion proteins does not require PA but is enhanced by PA in vitro. We also show that a single LFn fusion protein and PA can deliver antigen to both the MHC class II and the MHC class I pathways, resulting in the simultaneous induction of antigen-specific CD4+ T cells and antigen-specific CD8+ T cells in the same mouse. These results suggest that this toxin delivery system is capable of stimulating protective immune responses where effective immunization requires stimulation of both classes of T cells.


* Corresponding author. Mailing address: Department of Microbiology and Molecular Genetics, Harvard Medical School, 200 Longwood Ave., Boston, MA 02115. Phone: (617) 432-1873. Fax: (617) 738-7664. E-mail: starnbach{at}hms.harvard.edu

{triangledown} Published ahead of print on 17 March 2008.

Editor: V. J. DiRita


Infection and Immunity, June 2008, p. 2603-2611, Vol. 76, No. 6
0019-9567/08/$08.00+0     doi:10.1128/IAI.01718-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.